Inhaled Pentamidine For Pneumocystis jiroveci Prophylaxis in a Heart Transplant Recipient With Allergy for Trimethoprim Sulfamethoxazole

dc.contributor.authorAltıntaş, Garip
dc.contributor.authorKüçüker, Seref Alp
dc.contributor.authorHanedan, Onur
dc.contributor.authorDiken, Özlem Erçen
dc.contributor.authorDiken, Adem İlkay
dc.date.accessioned2026-04-01T07:52:06Z
dc.date.issued2011-02
dc.description.abstractPneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprim-sulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to trimethoprim sulfamethoxazole.
dc.identifier.citationExperimental and Clinical Transplantation, Cilt, 9, Sayı, 1, 2011 ss. 72-74en
dc.identifier.eissn2146-8427en
dc.identifier.issn1304-0855
dc.identifier.issue1en
dc.identifier.urihttps://hdl.handle.net/11727/14698
dc.identifier.volume9en
dc.language.isoen
dc.publisherBaşkent Üniversitesi
dc.sourceExperimental and Clinical Transplantationen
dc.subjectPentamidine
dc.subjectHeart transplantation
dc.subjectPneumocystis carinii
dc.subjectPneumocystis jiroveci
dc.titleInhaled Pentamidine For Pneumocystis jiroveci Prophylaxis in a Heart Transplant Recipient With Allergy for Trimethoprim Sulfamethoxazole
dc.typeCase Report

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
72.pdf
Size:
153.13 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: